News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
237 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (18719)
Month
January (2961)
February (3165)
March (3318)
April (3244)
May (4160)
June (3267)
July (3145)
August (3370)
September (3134)
October (4161)
November (3326)
December (2436)
Day
1 (198)
2 (220)
3 (181)
4 (191)
5 (122)
8 (164)
9 (186)
10 (150)
11 (151)
12 (109)
15 (183)
16 (188)
17 (185)
18 (184)
19 (127)
22 (190)
23 (212)
24 (222)
25 (237)
26 (165)
29 (156)
30 (236)
31 (204)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
8
9
10
11
12
15
16
17
18
19
22
23
24
25
26
29
30
31
Drug Development
Teva Neuroscience, Inc.: New Long-Term Analysis of Clinical Treatment Outcomes Demonstrated COPAXONE(R) is More Cost Effective Than Tysabri(R) for Treatment of Relapsing-Remitting Multiple Sclerosis
October 25, 2007
·
1 min read
Business
Regeneration Technologies Inc. Announces 2007 Third Quarter Results
October 25, 2007
·
1 min read
BioMidwest
Arteriocyte Medical Systems, Inc., Launched by DW Healthcare Partners
October 25, 2007
·
1 min read
Drug Development
Teva Neuroscience, Inc.: Study Showed Patients Using COPAXONE® Had Significantly Lower Risk of Relapse and Lower Medical Costs Compared to Patients Using Rebif® in Relapsing-Remitting Multiple Sclerosis (RRMS)
October 25, 2007
·
1 min read
FDA
Alphatec Holdings, Inc. Receives FDA 510(k) Clearance For the DYNAMO Rod System
October 25, 2007
·
1 min read
Business
Momenta Pharmaceuticals, Inc. Announces Appointment of Jo-Ann Beltramello as Vice President, Human Resources
October 25, 2007
·
1 min read
Drug Development
Infinity Pharmaceuticals, Inc. and MedImmune, Inc. Present Preliminary Phase 1 Data Demonstrating Biological Activity of IPI-504, A Novel Hsp90 Inhibitor, in Advanced Non-Small Cell Lung Cancer
October 25, 2007
·
1 min read
BioMidwest
BioForce Nanosciences Holdings, Inc. Announces Notice of Allowance for Its Sindex Chip Patent
October 25, 2007
·
1 min read
Business
Zecotek Medical Systems’s Patented LFS Scintillation Crystals Selected For Trials by the Paul Sherrer Institute Of Switzerland
October 25, 2007
·
1 min read
Biotech Beach
MediciNova, Inc. Announces Public Offering of Common Stock
October 25, 2007
·
1 min read
Previous
6 of 24
Next